At right, an example of successful serial single-cell electroporation on three consecutive days. The plasmids used: dsRed1-mito on day one, EYFP-Golgi on day two, and ECFP-vimentin on day three. To ...

Delivering nucleic acids into cells is a critical step during cell therapy product development. Electroporation allows researchers to transfect a large number of cells in a short time. However, ...

Pulsed electrical fields can be used to introduce DNA into a wide variety of animal cells 1,2. Electroporation works well with cell lines that are refractive to other techniques, such as calcium ...

Traditionally, creating these CUL5-deficient cells requires a process called electroporation, which uses electrical pulses to introduce changes into cells. However, this method can damage cells ...

They provide crucial technology for cell and gene therapies. Their core ExPERT ATx, sTX, GTx, and VLx tools use their proprietary technology called Flow Electroporation, which has been optimized ...

Last May, MaxCyte granted Legend Biotech a nonexclusive worldwide license to use its electroporation technology to develop and commercialize cell-based therapeutic products. Before that ...

The Gene Pulser Xcell System is a flexible, modular electroporation system for transfecting every cell type from primary, suspension, and difficult-to-transfect cells, including T cells, to bacteria ...

A recent study published in Engineering presents an innovative acoustofluidics-based approach for intracellular nanoparticle ...

MaxCyte (NASDAQ:MXCT – Free Report) had its price objective cut by Stifel Nicolaus from $11.00 to $9.00 in a report released on Wednesday morning,Benzinga reports. They currently have a buy rating on ...